| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $748.4M | +12.2% |
| Cost of Revenue | $266.8M | +10.9% |
| Gross Profit | $481.6M | +13.0% |
| R&D Expense | $83.7M | +25.6% |
| SG&A Expense | $178.7M | +16.9% |
| Operating Income | $2.3M | +204.6% |
| Pre-tax Income | $7.6M | +297.0% |
| Income Tax | $368K | -99.3% |
| Net Income | $7.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $314.0M | +6.1% |
| Accounts Receivable | $183.4M | +11.6% |
| Current Assets | $560.7M | +4.5% |
| Total Assets | $1.27B | +8.9% |
| Current Liabilities | $574.7M | +6.9% |
| Long-term Debt | $337.5M | +0.7% |
| Total Liabilities | $1.01B | +2.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $165.5M | +0.4% |
| Investing Cash Flow | -$123.7M | +21.8% |
| Financing Cash Flow | -$32.8M | -114.2% |
| +113.7% |
| Stockholders' Equity |
| $258.9M |
| +44.4% |